| 2021 |
Nicol L, Srikanth P, Henriksen K, Sun S, Smith R, Karsdal MA, Nagamani SC, Shapiro J, Lee B, Leder BZ, Orwoll E. Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta. Bone. January 2021;142:115703. |
0 |
0 |
| 2015 |
Tsai JN, Uihlein AV, Burnett-Bowie S-AM, Neer RM, Zhu Y, Derrico N, Lee H, Bouxsein ML, Leder BZ. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study. J Bone Miner Res. January 2015;30(1):39-45. |
19 |
17 |
| 2017 |
Tsai JN, Nishiyama KK, Lin D, Yuan A, Lee H, Bouxsein ML, Leder BZ. Effects of denosumab and teriparatide transitions on bone microarchitecture and estimated strength: the DATA-Switch HR-pQCT study. J Bone Miner Res. October 2017;32(10):2001-2009. |
14 |
13 |
| 2020 |
Leder BZ. What else do we need? a commentary on zoledronate effects on cancer and cardiac events. J Bone Miner Res. January 2020;35(1):18-19. |
1 |
1 |
| 2021 |
Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Leder BZ, Tsai JN. Effects of combination denosumab and high‐dose teriparatide administration on bone microarchitecture and estimated strength: the DATA‐HD HR‐pQCT study. J Bone Miner Res. January 2021;36(1):41-51. |
1 |
1 |
| 2021 |
Dempster DW, Zhou H, Rao SD, Recknor C, Miller PD, Leder BZ, Annett M, Ominsky MS, Mitlak BH. Early effects of abaloparatide on bone formation and resorption indices in postmenopausal women with osteoporosis. J Bone Miner Res. April 2021;36(4):644-653. |
4 |
3 |
| 2021 |
Ramchand SK, David NL, Lee H, Eastell R, Tsai JN, Leder BZ. Efficacy of zoledronic acid in maintaining areal and volumetric bone density after combined denosumab and teriparatide administration: DATA-HD study extension. J Bone Miner Res. May 2021;36(5):921-930. |
1 |
0 |
| 2023 |
Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Tsai JN, Leder BZ. The effect of zoledronic acid on bone microarchitecture and strength after denosumab and teriparatide administration: DATA-HD study extension. J Bone Miner Res. January 2023;38(1):26-34. |
0 |
0 |
| 2013 |
Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, Burnett-Bowie S-AM, Neer RM, Leder BZ. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet. July 6, 2013;382(9886):50-56. |
25 |
19 |
| 2015 |
Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie S-AM. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet. September 19-25, 2015;386(9999):1147. |
25 |
22 |